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Targeting branch sites of new exons?
Igor Vorechovsky
Martinez et al 1 reported an interesting case of Dubowitz-like syndrome associated with an acceptor splice site mutation, leading to the use of a cryptic splice donor site in an Alu sequence. Their explanation for the resulting aberrant transcripts was limited to a referral to Alu polyA tails and Aluderived microRNAs.
1 Upon mutation of acceptor sites, the spliceosome machinery tries to find suitable alternative 3 9 splice sites nearby. If none is available, which is the most likely scenario the downstream exon(s) is skipped or the mutated intron is retained in mature transcripts. If there is a suitable replacement in the pre-mRNA, the mutation may activate the upstream or downstream cryptic acceptor site(s) and still employ the authentic donor counterpart. 2 This was not the case in the reported family. The new donor splice site was weak, with a maximum entropy score of 6.79, which is below the average for natural 5 9 splice sites. 2 Clearly, the mutation activated an ideal cryptic 3 9 splice site in a downstream Alu element. 1 However, this transposon is in the antisense orientation in NSUN2 intron 6 (ref. 1) and does not therefore contain a polyA as the authors presented, but contains a polyuracil tail. This motif serves as a powerful 3 9 splice site activation motif in vertebrates, termed the polypyrimidine tract, with uracils providing generally superior signals over cytosines. 3 The polyuracil tracts in Alus critically influenced their exonisation in primates, contributing to new exon birth and evolutionary success of alternative splicing. 4 5 Thus, the defect in this family recapitulated an ancient RNA processing event that occurred many times in primate evolution, improved the fine-tuning of gene expression and expanded proteomic diversity.
However, even the optimal 3 9 splice site may not be sufficient for high-inclusion exonisation and overt phenotype unless additional splicing signals are present in primary transcripts, including a suitable branch site. I inspected the reference gene sequence just upstream of the polyuracil tract and found five adjacent adenines that would serve as a source of this preferred nucleobase for branch point recognition, and putative base-pairing interactions that contribute to the required pre-mRNA structure of the chosen acceptor. Using a branch point prediction tool, 6 this adenine stretch exactly co-localised with the predicted branch point sequence of the new exon. Although not applicable in this particular family, correction of cryptic exon activation by antisense oligonucleotides may therefore be further improved by co-targeting branch sites of new exons along with their splice sites and splicing enhancers.
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